The HealthWell Foundation funded Brukinsa (zanubrutinib) for Mike, enabling him to afford the treatment and maintain his ...
The question of whether invasive or noninvasive methods provide the best possible outcomes for patients with ...
A 67-year-old says a new £2,000 device, which is being studied by the NHS, has improved his sleep and allowed him to go back ...
MALVERN, PA — Annovis Bio, Inc. (NYSE: ANVS) said it will begin enrolling patients in January 2026 in a large, long-term study designed to assess whether its experimental Parkinson’s disease ...
Millions of people in the United States are affected by Parkinson’s disease and Lewy Body Dementia (LBD). These are both ...
Health professionals and community members recently gathered at the University of Arkansas for Medical Sciences (UAMS) Donald ...
Javascript must be enabled to use this site. Please enable Javascript in your browser and try again. Secure and simplify your digital life with Senior Planet from ...
Overactive immune response disrupts brain function before neuronal damage occurs. Tracking urea levels and nerve cell markers ...
A groundbreaking treatment for Parkinson’s disease and essential tremor is now available in Kentucky and the Norton ...
This discovery challenges long standing views of dopamine’s role in neurological disorders like Parkinson’s disease, a condition that affects more than 110,000 Canadians and millions worldwide.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback